Search

Search Constraints

You searched for: Author/Creator Aufderklamm, Stefan

Search Results

1. Alterations of the RANKL pathway in blood and bone marrow samples of prostate cancer patients without bone metastases. Issue 2 (19th June 2012)

2. Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma. Issue 5 (21st November 2012)

3. Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma. Issue 5 (21st November 2012)

5. Perioperative morbidity, bowel function and oncologic outcome after radical cystectomy and ileal orthotopic neobladder reconstruction: Studer-pouch versus I-pouch. Issue 1 (January 2018)

6. Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria. (22nd November 2011)

7. Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy. (29th January 2013)

8. Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy. (29th January 2013)

9. Significance of apoptotic and non‐apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancer. Issue 6 (13th January 2015)

10. Stepwise Application of Urine Markers to Detect Tumor Recurrence in Patients Undergoing Surveillance for Non-Muscle-Invasive Bladder Cancer. (22nd December 2014)